{"pageContent": "Aim: In prostate cancer, fiducial marker image-guided radiotherapy (FMIGRT) allows correction of setup errors and interfraction physiological motion resulting in improved accuracy of target and sparing of at risk organs. We aim to report outcomes and toxicities observed in patients treated with dose escalation to 78Gy with FMIGRT in our center.", "metaData": {"source": "\"Gotta Catch 'em All\", or Do We? Pokemet Approach to Metastatic Prostate Cancer\nhttps://pubmed.ncbi.nlm.nih.gov/28283344/"}}